Research Articles

March 01, 2021

Further Details Show Psilocybin to be a Budding New Autism Treatment

The Psychedelic Substance Supports Microbiome and Normalizes Serotonin Levels Last month, SafeMinds Shares reported on the stir psilocybin was creating in the financial world.  Market analysts and investors were viewing the psychedelic as a potential revolutionary autism treatment.  The autism treatment market is currently valued at $3.2 billion and is desperately lacking in drug therapies. […]

February 21, 2021

Cognitive Training Using Virtual Reality Effective for Kids on the Spectrum

The New Technology Provides a Safe Controllable Environment for Therapies A recent study published in Current Research in Behavioral Sciences theorizes that cognitive training through the use of virtual reality (VR) technology may now be a feasible autism treatment. Researchers have been interested in using VR to help children with autism connect with the world […]

February 15, 2021

Chronic Viral Encephalopathy Mistaken for Schizophrenia

16-Year-Old Boy Lost Psychiatric Symptoms After Antiviral Treatment A recent case report published in the British Medical Journal features the account of a teenage boy who had been experiencing symptoms of paranoid ideation, anxiety, fear and hallucinations for a period of three months. A psychiatric hospital diagnosed the teen with schizophrenia and prescribed the antipsychotic […]

February 15, 2021

Decreased Phenol Sulfotransferase Linked to Common Autism Biomarker

Hyperserotonemia Has Been Associated with ASD for Decades for Unknown Reasons Until Now Hyperserotonemia is the state of increased whole blood serotonin within the body. The condition is the most replicated biochemical abnormality associated with autism spectrum disorders (ASD). The etiology of this biomarker was poorly understood until now. A new French study published in […]

February 15, 2021

Another Suramin Study Shows Promise for Treating Core Symptoms of Autism

Research Involved an Intravenous Form of Suramin Called PAX-101 Exciting news surrounding a potential autism medication was delivered from New Jersey last week. PaxMedica, a biopharmaceutical company, announced impressive results from their phase 2 dose-ranging clinical trial investigating their product PAX-101 (IV suramin) as a potential therapeutic to alleviate core symptoms of autism spectrum disorder […]

February 15, 2021

Most Medical Doctors View the Lives of Individuals with Disabilities as Subpar

Lead Author of New Study Calls Findings, “Very Disturbing”  Approximately 12% of  Americans have at least one disability. Growing evidence shows that individuals living with disabilities experience healthcare disparities compared to the general population. A new study published in the journal Health Affairs was the first of its kind to examine doctors’ attitudes on treating […]

Show Buttons
Hide Buttons